Stem cell therapy has stirred much excitement and controversy in recent years, as the medicine advances to become a cure very few therapies can do. From neurological disorders to chronic diseases, stem cells may be the new frontier of medical research promising cures for everything.
But, it is not as simple as it sounds because stem cell therapy is a new field and undergoing tests — hence risky· too. The aim of this article is to give patients and providers most of the basics needed for you to have a good idea about stem cell therapy, understand better FDA oversight and be sure going in what kind of choice is being made when it comes to getting treatment.
Stem cells are ‘raw material’ cells within the human body that have the remarkable ability to develop into various types of cells. Let's say the body needs to create new bone cells; it calls upon stem cells which then morph into bond cells at the site where they are needed. They can create all sorts of human cells: blood, brain, bone, and organ cells–you name it!.
Another way medical practitioners refer to stem cells is "master cells.” They play a critical role in maintaining and repairing the tissues of our body. They can regenerate and differentiate into multiple cells. This is what got researchers thinking, “what if we could use the abilities of stem cells to regrow body organs/parts?”. That question is what makes stem cell therapy such an interesting topic. The goal of stem cell therapy, therefore, is to find ways to use stem cells to generate new bodily cells for humans at will. This potentially gives them significant therapeutic benefits.
Types of Stem Cells
Stem cells can be broadly classified into three categories:
Embryonic Stem Cells (ESCs): Stem cells with pluripotency that originate from the inner mass of a blastocyst, an early stage of pre-implantation embryo, are known as embryonic stem cells. Four to five days after fertilization, human embryos reach the blastocyst stage, when they are made up of fifty to one hundred fifty cells.
Adult Stem Cells(ASCs): These cells are present anywhere in the body of an adult human in different tissues. The problem with these is that they are less malleable in terms of being formed into different types of cells than embryonic stem cells. Therefore, adult stem cells have a lower plasticity towards changing to any kind of tissue. But there are still some cases where they work, namely in blood and immune related diseases.
Induced Pluripotent Stem Cells (iPSCs): These are also adult cells but they are a step further through genetic reprogramming. They replicate the embryonic stem cells to overcome the disadvantage that is associated with the use of the adult stem cell. This gives them the capacity to differentiate like embryonic stem cells in every way as we have seen.
There are quite a few potential applications we can anticipate. Some of which are:
Neurodegenerative Diseases: Applying these concepts means that we have a tool to treat neurologic diseases which are not curable including Parkinson. This means that, for instance, the nerve cells that were affected may regain a certain ability of regeneration after this therapy.
Cardiac Diseases: Stem cells may be the absolute solution for fixing tissues damaged heart tissues.
Diabetes: The hope is to use stem cells in order for insulin-producing cell growth to occur inside the pancreas.
Stem cells and Orthopedic Conditions: The Stem Cells straighten to form new bones. Stem cells and Orthopedic Conditions: This could make it possible to heal broken bones, cartilage and muscles.
FDA’s Role in Regulating Stem Cell Therapies
The FDA regulates stem cells taken from cord blood for unrelated allogeneic usage, and distribution of these products necessitates a license. In order for the FDA to ensure that the necessary measures are taken to ensure purity and potency, the FDA mandates a review procedure in which manufacturers must demonstrate how products will be created.
Approval process
One cannot underestimate the responsibilities of the FDA in the approval of stem cell therapy products. Each therapy must first pass through the FDA’s battery of analysis,which may include:
Preclinical Studies: These are laboratory and animal studies used for the safety testing of a potential therapy.
Investigational New Drug Application (IND): Preclinical studies must go well if a therapy's developers want to seek an IND from the FDA for further testing. Applications should detail what the product is made of, how it's manufactured and its preclinical study information. The IND grants permission from the FDA to test the therapy in human clinical trials.
Clinical Trials: Phases of clinical trials range from a small number of patients to determine safety, use in more people and increasingly larger groups to ensure efficacy, monitor side effects, test for drug interactions with other drugs or dietary supplements before the study is completed. The trials are key in establishing whether the therapy is safe and effective to be approved for more widespread use.
Current FDA-Approved Stem Cell Treatments and Risks of Unapproved Therapies
Approved Therapies
Currently, the FDA has only approved a few stem cell-based medications that involve blood-forming (hematopoietic) elements. Working cells for patients related to diseases of hematopoietic system where blood formation occurs is applied. These are approved uses and include treating certain blood cancers (eg, leukemia) or related disorders like aplastic anemia.
Transplant using HPCs is now a routine treatment for some patients with certain blood and immune system diseases. Stem cell transplants are used to rebuild healthy blood cells in people whose bone marrow has been damaged by disease or strong treatments, such as high-dose chemotherapy.
Some of the recent examples include patients with leukemia who have gone into remission after cord blood transplants. These cases illustrate the efficacy of stem cell treatments if the therapy is approved and delivered under the correct circumstances.
FDA Enforcement and Actions
As in the case with unregulated stem cell clinics, there is no doubt that a dramatic rise in the number of these facilities has galvanized FDA enforcement efforts like never before. That includes sending out warning letters, making inspections and pursuing other enforcement actions against clinics that violate FDA rules.
The FDA has also taken clinics to court that are manufacturing unapproved and potentially dangerous stem cell therapies. Most of the time, these actions resulted in lawsuits, injunctions or even criminal filings. Aggressive enforcement of this kind is crucial to safeguarding the integrity of medical care and public health.
The FDA continues to monitor stem cell clinics across the country, ensuring that they comply with regulations and do not pose undue risks to patients. This ongoing surveillance is a key component of the FDA’s strategy to prevent harm and promote the safe development of new therapies.
Conclusion
The safest way to access experimental stem cell therapies is through a clinical trial that has been approved by the FDA under an IND. A clinical trial is a prospective study that follows patients forward in time, intended to ensure the safety of both participants and delivery of data regarding whether a therapy does more good than harm.
Patients should be sure to check with the FDA that any kind of stem cell treatment they are considering has been viewed and accepted. The sponsor can provide evidence of this, for example by sharing the FDA-issued Investigational New Drug Application number or similar documentation establishing regulatory supply.
Looking for a bladder scanner for your nursing home or rehabilitation center? Discover the top-rated models and learn how to choose the right one for your staff.
